Jonathan J. Havel

15.7k total citations · 2 hit papers
14 papers, 2.7k citations indexed

About

Jonathan J. Havel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jonathan J. Havel has authored 14 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Jonathan J. Havel's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (2 papers). Jonathan J. Havel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (2 papers). Jonathan J. Havel collaborates with scholars based in United States, China and Japan. Jonathan J. Havel's co-authors include Timothy A. Chan, Diego Chowell, Alexis Desrichard, Nadeem Riaz, Luc G.T. Morris, Rajarsi Mandal, Yasin Şenbabaoğlu, A. Ari Hakimi, Ken-Wing Lee and Ian Ganly and has published in prestigious journals such as Nature Genetics, Nature reviews. Cancer and Oncogene.

In The Last Decade

Jonathan J. Havel

14 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

2019 1.6k citations Jonathan J. Havel, Diego Chowell et al. Nature reviews. Cancer profile →
The head and neck cancer immune landscape and its immunotherapeutic implications

2016 551 citations Rajarsi Mandal, Yasin Şenbabaoğlu et al. JCI Insight profile →

Peers

Jonathan J. Havel

ONCOL

IMMUN

MB

PRM

CR

Shijun Kang China

Alexis Desrichard United States

Simon J. Dovedi United Kingdom

Jason Madore Australia

Khalid Al‐Shibli Norway

Sean P. Pitroda United States

Joe Yeong Singapore

Viswam S. Nair United States

Asma Tulbah Saudi Arabia

Hiroko Asanuma Japan

Shijun Kang China

Jonathan J. Havel

2.0k ×1.1

ONCOL

1.2k ×1.1

IMMUN

881 ×1.1

MB

853 ×1.2

PRM

552 ×1.1

CR

Citations per year, relative to Jonathan J. Havel Jonathan J. Havel (= 1×) peers Shijun Kang

Countries citing papers authored by Jonathan J. Havel

Since Specialization

Citations

This map shows the geographic impact of Jonathan J. Havel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Havel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Havel more than expected).

Fields of papers citing papers by Jonathan J. Havel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Havel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Havel. The network helps show where Jonathan J. Havel may publish in the future.

Co-authorship network of co-authors of Jonathan J. Havel

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Havel. A scholar is included among the top collaborators of Jonathan J. Havel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Havel. Jonathan J. Havel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Sabio, Erich, Chirag Krishna, Xiaoxiao Ma, et al.. (2021). Qa-1b Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing. Molecular Cancer Research. 19(6). 1076–1084. 13 indexed citations

2.

Bessell, Catherine, Ariel Isser, Jonathan J. Havel, et al.. (2020). Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight. 5(8). 125 indexed citations

3.

Havel, Jonathan J., Diego Chowell, & Timothy A. Chan. (2019). The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nature reviews. Cancer. 19(3). 133–150. 1591 indexed citations breakdown →

4.

Sidhom, John-William, Catherine Bessell, Jonathan J. Havel, et al.. (2017). ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis. Cancer Immunology Research. 6(2). 151–162. 31 indexed citations

5.

Zhu, Gangcai, et al.. (2017). PRAS40 promotes NF-κB transcriptional activity through association with p65. Oncogenesis. 6(9). e381–e381. 15 indexed citations

6.

Mo, Xiulei, Qi Qi, Andrei A. Ivanov, et al.. (2017). AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay. Molecular Pharmacology. 91(4). 339–347. 21 indexed citations

7.

Riaz, Nadeem, Jonathan J. Havel, Sviatoslav M. Kendall, et al.. (2016). Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. Nature Genetics. 48(11). 1327–1329. 101 indexed citations

8.

Mandal, Rajarsi, Yasin Şenbabaoğlu, Alexis Desrichard, et al.. (2016). The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight. 1(17). e89829–e89829. 551 indexed citations breakdown →

9.

Riaz, Nadeem, Luc G.T. Morris, Jonathan J. Havel, et al.. (2016). The role of neoantigens in response to immune checkpoint blockade. International Immunology. 28(8). 411–419. 125 indexed citations

10.

Mo, Xiulei, Yin Luo, Andrei A. Ivanov, et al.. (2015). Enabling systematic interrogation of protein–protein interactions in live cells with a versatile ultra-high-throughput biosensor platform. Journal of Molecular Cell Biology. 8(3). 271–281. 26 indexed citations

11.

Havel, Jonathan J. & Timothy A. Chan. (2015). High-resolution genomic analysis: the tumor-immune interface comes into focus. Genome biology. 16(1). 65–65. 3 indexed citations

12.

Havel, Jonathan J., Zijian Li, Dai Cheng, Peng Jin, & Huimin Fu. (2014). Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene. 34(12). 1487–1498. 48 indexed citations

13.

Arkin, Michelle R., Marcie A. Glicksman, Haian Fu, Jonathan J. Havel, & Yuhong Du. (2012). Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats. Journal of Computer Assisted Tomography. 7(1). 151–3. 23 indexed citations

14.

Huang, Wen‐Chin, Jonathan J. Havel, Haiyen E. Zhau, et al.. (2008). β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells. Clinical Cancer Research. 14(17). 5341–5347. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact